TrialHaematologica2026

HLA-haploidentical hematopoietic stem cell transplantation in patients with sickle cell disease: results from the phase II DREP-HAPLO trial.

Nathalie Dhedin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.